Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study tests supplement to fix nutrient gaps in ozempic users

NCT ID NCT07437911

Recruiting now Disease control Sponsor: Athletic Greens International Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a nutritional supplement called AG1 can help fill nutrient gaps and improve gut health in 120 adults taking GLP-1 medications like Ozempic or Wegovy. Participants will take either the supplement or a placebo for a period, and researchers will measure changes in their diet, blood nutrient levels, and gut bacteria. The goal is to see if the supplement can support overall health in people using these popular weight-loss drugs.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
AG1 nutritional supplement
What this could lead to
If it works, this could show that a simple daily supplement helps GLP-1 users avoid nutrient deficiencies and support gut health while on these medications.
What could go wrong
This is a small, early-stage trial with no phase, so results may not apply to everyone. The supplement may not improve nutrient levels or gut health more than a placebo.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTROINTESTINAL MICROBIOME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GASTROINTESTINAL MICROBIOME GLP-1 NUTRITION INTAKE NUTRITION STATUS

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Citruslabs

    RECRUITING

    Santa Monica, California, 90404-3727, United States

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.